Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Eywa Pharma Inc, priced at $0.1256 per EA under NDC 71930002013. Its NADAC has been published 55 times since Nov 5, 2025.

FDA first approved this application on Oct 30, 2017. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1256per EA
DEA Schedule CII

Strength

325; 7.5 mg/1; mg/1

Manufacturer

Eywa Pharma Inc

NDC

71930002013

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210211

FDA Approved

10/30/2017

TE Code

AA

On Market Since

7/13/2018

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 55 times since Nov 5, 2025, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1256 per EA
All-time high$0.1501 (Nov 12, 2025)
All-time low$0.1256 (Nov 18, 2026)
52-week high$0.1485
52-week low$0.1256
Median price$0.1389
Average price$0.1393
Largest weekly change-4.2% (Dec 17, 2025)
Weeks tracked55
Tracking sinceNov 5, 2025

Price History

1W

-3.8%

1M

-7.2%

3M

-9.1%

6M

-9.0%

1Y

-16.3%

3Y

N/A

5Y

N/A

All

-16.3%

Generic Alternatives

The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Eywa Pharma Inc, is $0.1256 per EA (NDC 71930002013), effective Nov 18, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 16.3%. It has been tracked across 55 weekly CMS publications since Nov 5, 2025.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Since Nov 5, 2025, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.1256 (Nov 18, 2026) to a high of $0.1501 (Nov 12, 2025), with a median of $0.1389 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

13 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 71930002013) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.